Citius Oncology Inc stock is traded at $0.5001, with a volume of 145,674. It is down -8.57% in the last 24 hours and down -42.75% over the past month. Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies.The Company centers on achieving a market position by advancing therapies with reduced development and clinical risks, and competitive advantages supported by intellectual property and regulatory exclusivity protection. This includes new formulations of previously approved drugs with substantial existing safety and efficacy data or expanded indications for approved therapies. The company focused on key geographies and stakeholders, majorly on cancer centers and patients.
Previous Close:
$0.547
Open:
$0.5481
24h Volume:
145,674
Relative Volume:
0.59
Market Cap:
$52.89M
Revenue:
$5.61M
Net Income/Loss:
-$42.51M
P/E Ratio:
-
EPS:
-$0.466
Net Cash Flow:
-$16.86M
1W Performance:
-5.55%
1M Performance:
-42.75%
6M Performance:
-47.74%
1Y Performance:
-67.53%
1-Day Range:
$0.4936$0.5775
1-Week Range:
$0.4936$0.694
52-Week Range:
$0.4912$1.83
Citius Oncology Inc Stock (CTOR) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS